BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14629622)

  • 1. Adjuvant activity of free Bordetella pertussis filamentous haemagglutinin delivered by mucosal routes.
    Poulain-Godefroy O; Menozzi FD; Alonso S; Vendeville C; Capron A; Locht C; Riveau G
    Scand J Immunol; 2003 Nov; 58(5):503-10. PubMed ID: 14629622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.
    Poulain-Godefroy O; Mielcarek N; Ivanoff N; Remoué F; Schacht AM; Phillips N; Locht C; Capron A; Riveau G
    Infect Immun; 1998 Apr; 66(4):1764-7. PubMed ID: 9529111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella pertussis filamentous hemagglutinin delivered by mucosal routes enhances immunoglobulin levels in serum and mucosal fluids.
    Poulain-Godefroy O; Vendeville C; Locht C; Riveau G
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):129-36. PubMed ID: 18680517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
    Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I; Fisher AN; Rappuoli R; Davis SS; Illum L
    Vaccine; 1998 Dec; 16(20):2039-46. PubMed ID: 9796062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human dendritic cell maturation and cytokine secretion upon stimulation with Bordetella pertussis filamentous haemagglutinin.
    Dirix V; Mielcarek N; Debrie AS; Willery E; Alonso S; Versheure V; Mascart F; Locht C
    Microbes Infect; 2014 Jul; 16(7):562-70. PubMed ID: 24801497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
    Colombi D; Horton DS; Oliveira ML; Sakauchi MA; Ho PL
    FEMS Microbiol Lett; 2004 Nov; 240(1):41-7. PubMed ID: 15500977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.
    Guzman CA; Molinari G; Fountain MW; Rohde M; Timmis KN; Walker MJ
    Infect Immun; 1993 Feb; 61(2):573-9. PubMed ID: 8423087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.
    Alonso S; Willery E; Renauld-Mongénie G; Locht C
    Infect Immun; 2005 Jul; 73(7):4295-301. PubMed ID: 15972522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
    Shahin RD; Amsbaugh DF; Leef MF
    Infect Immun; 1992 Apr; 60(4):1482-8. PubMed ID: 1548072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M; Cropley I; Chatfield S; Dougan G
    Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model.
    Watanabe M; Komatsu E; Abe K; Iyama S; Sato T; Nagai M
    Vaccine; 2002 Jan; 20(9-10):1429-34. PubMed ID: 11818163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
    Castro JT; Oliveira GS; Nishigasako MA; Debrie AS; Miyaji EN; Soares-Schanoski A; Akamatsu MA; Locht C; Ho PL; Mielcarek N; Oliveira MLS
    PLoS One; 2020; 15(1):e0228055. PubMed ID: 31945121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
    Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydromechanical forces on the production of filamentous haemagglutinin and pertussis toxin of Bordetella pertussis.
    Rodríguez ME; Samo AL; Hozbor DF; Yantorno OM
    J Ind Microbiol; 1993 Feb; 12(2):103-8. PubMed ID: 7764157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.